Get the Stockscreener App
8.64
0.00%
0.00
After Hours:
8.72
0.08
+0.93%
Delcath Systems Inc stock is traded at $8.64, with a volume of 1.11M.
It is up +0.00% in the last 24 hours and down -20.00% over the past month.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
See More
Previous Close:
$8.64
Open:
$8.65
24h Volume:
1.11M
Relative Volume:
1.32
Market Cap:
$302.24M
Revenue:
$2.07M
Net Income/Loss:
$-47.68M
P/E Ratio:
-3.0638
EPS:
-2.82
Net Cash Flow:
$-31.31M
1W Performance:
-12.11%
1M Performance:
-20.00%
6M Performance:
-25.58%
1Y Performance:
-21.02%
1-Day Range:
$8.33
$8.70
1-Week Range:
$8.33
$9.90
52-Week Range:
$8.33
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
Name
Delcath Systems Inc
Sector
Industry
Phone
(518) 743-8892
Address
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Compare DCTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
8.64 | 305.11M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
126.36 | 217.27B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.02 | 146.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
356.03 | 135.31B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
92.20 | 115.51B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.39 | 47.84B | 5.88B | 1.34B | 577.90M | 2.3455 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-28-24 | Initiated | Craig Hallum | Buy |
| May-14-24 | Initiated | Stephens | Overweight |
| Jul-26-22 | Resumed | Canaccord Genuity | Buy |
| Dec-10-21 | Initiated | H.C. Wainwright | Buy |
| Mar-09-21 | Initiated | Canaccord Genuity | Buy |
| Jan-05-21 | Initiated | BTIG Research | Buy |
| Jun-01-20 | Initiated | Laidlaw | Buy |
View All
Delcath Systems Inc Stock (DCTH) Latest News
Why Delcath Systems Inc. (DV3R) stock trades below fair valueMarket Activity Report & Reliable Volume Spike Alerts - newser.com
Delcath Systems Q1 EPS Forecast Boosted by HC Wainwright - MarketBeat
Volatility clustering patterns for Delcath Systems Inc.2025 Dividend Review & Risk Controlled Daily Trade Plans - newser.com
Real time breakdown of Delcath Systems Inc. stock performanceForecast Cut & Daily Risk Controlled Trade Plans - newser.com
What insider purchases suggest about Delcath Systems Inc. (DV3R) stockCPI Data & AI Powered Buy and Sell Recommendations - newser.com
Delcath Systems to Participate in Upcoming November 2025 Investor Conferences - BioSpace
Delcath Systems, Inc. (NASDAQ:DCTH) Q3 2025 Earnings Call Transcript - Insider Monkey
Delcath (NASDAQ: DCTH) to join Craig-Hallum and Canaccord MedTech forums Nov 18, 20 - Stock Titan
Delcath: Temporary Headwinds Are No Cause For Concern (NASDAQ:DCTH) - Seeking Alpha
Stephens Has Lowered Expectations for Delcath Systems (NASDAQ:DCTH) Stock Price - MarketBeat
Delcath Systems (DCTH) Profitability and Margin Gains Reinforce Value Bull Case, Despite Dilution Concerns - Yahoo Finance
Can volume confirm reversal in Delcath Systems Inc.2025 Support & Resistance & Safe Entry Zone Tips - newser.com
Will Delcath Systems Inc. benefit from macro trends2025 Key Highlights & Stepwise Swing Trade Plans - newser.com
Is it time to cut losses on Delcath Systems Inc.Market Movers & Consistent Growth Equity Picks - newser.com
How to use a screener to detect Delcath Systems Inc. breakoutsWeekly Investment Report & Weekly Watchlist of Top Performers - newser.com
Is Delcath Systems Inc. stock bottoming out2025 Earnings Impact & Daily Market Momentum Tracking - newser.com
Is Delcath Systems Inc. showing signs of accumulation2025 Year in Review & Smart Money Movement Tracker - newser.com
Will Delcath Systems Inc. (DV3R) stock issue positive guidanceEarnings Recap Summary & Weekly Top Gainers Trade List - newser.com
Delcath Systems’ Earnings Call: Mixed Sentiments and Future Plans - TipRanks
Will Delcath Systems Inc. stock reach all time highs in 2025Earnings Recap Summary & Weekly High Return Stock Opportunities - newser.com
BTIG Research Reaffirms Buy Rating for Delcath Systems (NASDAQ:DCTH) - MarketBeat
Delcath Systems (DCTH) Analyst Rating Update: Price Target Lowered to $18 | DCTH Stock News - GuruFocus
Delcath Systems (NASDAQ:DCTH) Releases Earnings Results, Beats Expectations By $0.10 EPS - MarketBeat
Delcath outlines 40 active center target and 150% HEPZATO treatment volume growth for 2025 amid CHOPIN data momentum - MSN
Forecasting Delcath Systems Inc. price range with options dataEarnings Overview Summary & Expert Approved Momentum Ideas - newser.com
Evaluating Delcath Systems Inc. with trendline analysis2025 Top Decliners & AI Driven Price Predictions - newser.com
Delcath Systems Reports Third Quarter 2025 Results and Business Highlights - BioSpace
Delcath Systems Reports Strong Q3 2025 Growth - TipRanks
BTIG Reiterates Delcath Systems (DCTH) Buy Recommendation - Nasdaq
Should Delcath Systems' Transition to Year-to-Date Profitability Prompt a Rethink for DCTH Investors? - Yahoo Finance
Delcath Systems Inc (DCTH) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Delcath’s Revenue Misses But HEPZATO Sales Power Optimism - Finimize
BTIG Reiterates Buy Rating for Delcath Systems (DCTH) with $23 P - GuruFocus
Earnings call transcript: Delcath Systems Q3 2025 results disappoint investors By Investing.com - Investing.com Nigeria
Is Delcath Systems’ First Nine-Month Net Profit Reshaping the Investment Case for DCTH? - simplywall.st
Delcath Systems Inc Reports Q3 2025 Revenue of $20.6M, Slightly Missing Estimates; Net Income at $0.8M - GuruFocus
Delcath Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Delcath Systems, Inc. (DCTH) Q3 Earnings Match Estimates - Yahoo! Finance Canada
Delcath Systems Inc. Reveals Retreat In Q3 Bottom Line, But Beats Estimates - Nasdaq
Cancer therapy developer Delcath Q3 revenue misses estimates - MarketScreener
Order flow analysis tools used on Delcath Systems Inc.July 2025 Sector Moves & Consistent Profit Trade Alerts - newser.com
Will Delcath Systems Inc. stock maintain growth storyMarket Activity Report & Technical Buy Zone Confirmation - fcp.pa.gov.br
Delcath Systems Inc Stock (DCTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.21%
1.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):